Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-29

Clinical Trial Update: Safety of Treatment of Uterine Fibroids With Asoprisnil [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting on the safety of treating uterine fibroids with asoprisnil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asoprisnil (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Fibroid Uterus, Leiomyoma | Phase 3 | Status: COMPLETED